News

• 10/2019: Invitation to the General Meeting 2019 of GLA e.V.
  
  Dear GLA Members,
  the GLA e.V. Executive Board is pleased to invite you to the GLA e.V. General Assembly 2019, which will take place on November 15, 2019 at 8.30 am in the Cloud Room of the Factory Hotel Münster.
• 9/2019: Download GLA-Newsletter 02/2019
• 1/2019: Download GLA-Newsletter 01/2019
• 8/2018: Consensus statement of the GLA, DGHO and DAB-KBT for the Allogeneic Stem Cell Transplantation for patients with aggressive lymphoma submitted to the IQWiG
• 8/2018: 200 Patients randomized in the ECWM-1 trial for the first-line treatment of Waldenstrom Macroglobulinemia (Contact person: Prof. Dr. C. Buske)
• 8/2018: OLYMP-1 trial for the first-line treatment with Obinutuzumab monotherapy will start in August in Germany (Contact person: Prof. Dr. C. Buske)
• 7/2018: New ESMO guidelines for Waldenstrom Macroglobulinemia published (Contact person: Prof. Dr. C. Buske)
• 7/2018: Study results of the innovate trial for the treatment of Waldenstroems Macroglobulinemia with Ibrutinib/Rituximab published in the New England Journal (Contact person: Prof. Dr. C. Buske)
• 7/2018: 7/2018: European Triangle Study for younger patients with Mantle Cell Lymphoma hits planned recruited rate: 232 patients already recruited in July 2018. (Contact person: Prof. Dr. M. Dreyling)
• 6/2018: MCL Elderly Study for treatment of elderly patients with Mantle Cell Lymphoma with over 400 recruited patients.